Mangoceuticals (MGRX) EBT Margin (2023 - 2026)
Mangoceuticals' (MGRX) quarterly EBT Margin came in at 5014.65% in Q1 2026, down 58718.0% year-on-year from N/an in Q1 2025, and down 70.86% quarter-over-quarter from 2934.9% in Q4 2025.
Mangoceuticals (MGRX) EBT Margin (2023 - 2026) Analysis & Trends
Mangoceuticals has disclosed EBT Margin across 4 years of filings, most recently posting 5014.65% for Q1 2026.
- EBT Margin for Q1 2026 came in at 5014.65%, down 58718.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4632.92% (down 244559.0% YoY), and the FY2025 annual result was 4526.86%, down 311306.0% from the prior year.
- EBT Margin came in at 5014.65% for Q1 2026 at Mangoceuticals, down from 2934.9% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 733.99% in Q3 2023 to a low of 9043.49% in Q3 2025.
- The 4-year median for EBT Margin is 1851.45% (2024), against an average of 2808.38%.
- Across the five-year window, EBT Margin soared 143666 bps in 2024 and slumped 754411 bps in 2025, its largest moves.
- Mangoceuticals' EBT Margin stood at 1050.87% in 2023, then plunged by 76 bps to 1851.45% in 2024, then sank by 59 bps to 2934.9% in 2025, then tumbled by 71 bps to 5014.65% in 2026.
- The last three EBT Margin figures came in at 5014.65% (Q1 2026), 2934.9% (Q4 2025), and 9043.49% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 39.36% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 2.29% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 26.06% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 19.72% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -8.52% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 22.10% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 19.06% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 1.54% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 5.46% |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | -5,014.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,014.65% |
| Dec 31, 2025 | -2,934.90% |
| Sep 30, 2025 | -9,043.49% |
| Jun 30, 2025 | -3,221.61% |
| Mar 31, 2025 | -4,427.47% |
| Dec 31, 2024 | -1,851.45% |
| Sep 30, 2024 | -1,499.38% |
| Jun 30, 2024 | -1,465.60% |
| Mar 31, 2024 | -1,105.87% |
| Dec 31, 2023 | -1,050.87% |
| Sep 30, 2023 | -733.99% |
| Jun 30, 2023 | -1,617.16% |
| Mar 31, 2023 | -2,542.53% |